Cat.#: ACPP-1237
| Despition | CRMP1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1660 | Mouse GDF7 Protein (AC1660) | 2 µg | inquiry |
| ACPP-1600 | Mouse IL 6 Protein, Sf9 (AC1600) | 2 µg | inquiry |
| ACPP-1708 | Human PRNP Protein (AC1708) | 2 µg | inquiry |
| ACPP-1652 | Human WWC1 Protein (AC1652) | 5 µg | inquiry |
| ACPP-1265 | EDG8 Blocking Peptide (AC1265) | 250 µg | inquiry |
| ACPP-1122 | Synthetic Membrane Nanoparticle Human Adenosine Receptor A2a Protein (AC1122) | 50 µg | inquiry |
| ACPP-1577 | Human WWOX Protein (AC1577) | 2 µg | inquiry |
| ACPP-1440 | Human SIRPA Protein (AC1440) | 5 µg | inquiry |
| ACPP-1385 | Human TGFBI Protein (AC1385) | 5 µg | inquiry |
| ACPP-1240 | PAX5 Blocking Peptide (AC1240) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.